Endpoint Clinical

Endpoint Clinical is a global leader in randomization and trial supply management (RTSM) solutions, providing interactive response technology (IRT®) systems and services for clinical trials in the life sciences and pharmaceutical industries. Founded in 2009 and headquartered in Wakefield, Massachusetts, the company employs over 600 people and generates approximately $126 million in revenue. Endpoint has supported more than 2,000 studies across 90+ countries, managing over 650,000 patients and 90,000 sites. The company specializes in built-for-purpose RTSM solutions that combine advanced technology with tailored services. Key offerings include IRT® systems for clinical trials, randomization and clinical supply chain management, and electronic patient-reported outcomes (ePRO). Endpoint emphasizes speed to market, flexibility, and proactive support, allowing manufacturers to focus on core trial execution. Recently acquired by Arsenal Capital Partners, Endpoint continues to enhance its technology and operational processes while maintaining a hybrid work model.